I
Iris E. C. Sommer
Researcher at University Medical Center Groningen
Publications - 454
Citations - 20580
Iris E. C. Sommer is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Schizophrenia & Medicine. The author has an hindex of 68, co-authored 394 publications receiving 16545 citations. Previous affiliations of Iris E. C. Sommer include University of Toronto & University of Michigan.
Papers
More filters
Journal ArticleDOI
Visual hallucinations and lifetime use of HPPD-related drugs: Results from a large online survey
Journal ArticleDOI
Hallucinations in Hearing Impairment: How Informed Are Clinicians?
Theresa M Marschall,Pim van Dijk,Karolina Kluk,Sanne Koops,Mascha M. J. Linszen,Timothy D. Griffiths,Wei Lin Toh,Alicja N. Malicka,Damir Kovačić,Christoph Mulert,Iris E. C. Sommer,Branislava Ćurčić-Blake +11 more
TL;DR: In this article , an online survey was conducted investigating awareness of auditory hallucinations among clinicians and their opinions about these hallucinations among 125 clinicians across 10 countries, including audiologists, audiologists and ear-nose-throat (ENT) specialists.
Journal ArticleDOI
Recreational Drug Use and Distress From Hallucinations in the General Dutch Population.
TL;DR: In this paper , the authors investigated whether recreational drug use by individuals from the general population is associated with the degree of distress experienced from auditory (AH) and visual (VH) hallucinations.
Journal ArticleDOI
Na tien jaar eindelijk minder last van stemmen: COMET bij auditieve verbale hallucinaties
TL;DR: In this article, a gecombineerde behandelmethode for patienten with auditieve verbale hallucinaties, and bij wie medicatie niet voldoende helpt, beter te leren omgaan met hun stemmen and ze mogelijk doen verdwijnen.
Journal ArticleDOI
Use of cardiovascular and antidiabetic drugs before and after starting with clozapine versus other antipsychotic drugs: a Dutch database study.
TL;DR: Reports of decreased mortality among patients with schizophrenia who use clozapine may be biased if clozAPine is prescribed to relatively healthy patients and if intensive monitoring during its use prevents (under-treatment of) somatic disorder.